Novozymes A/S (OTCMKTS:NVZMY) Sees Large Volume Increase – What’s Next?

Shares of Novozymes A/S (OTCMKTS:NVZMY) saw strong trading volume on Tuesday. Approximately 184,380 shares traded hands during trading, an increase of 216% from the average daily volume of 58,320 shares. The stock last traded at $66.1020 and had previously closed at $68.58.

Novozymes A/S Price Performance

The stock has a market capitalization of $27.44 billion, a PE ratio of 39.17, a P/E/G ratio of 3.08 and a beta of 0.86. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.74 and a quick ratio of 1.04. The firm’s 50 day simple moving average is $67.43 and its 200 day simple moving average is $62.68.

Novozymes A/S (OTCMKTS:NVZMY) last released its earnings results on Thursday, November 5th. The biotechnology company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.26). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.28 billion. Novozymes A/S had a net margin of 14.70% and a return on equity of 6.54%. As a group, equities analysts forecast that Novozymes A/S will post 2.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Novozymes A/S stock. Elefante Mark B increased its stake in Novozymes A/S (OTCMKTS:NVZMY) by 73.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,900 shares of the biotechnology company’s stock after acquiring an additional 2,500 shares during the period. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent SEC filing. 0.03% of the stock is currently owned by institutional investors.

About Novozymes A/S

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.